Actos /Usa/


Combined with:

Byetta

Indications and Reactions:

Role Indications Reactions
Secondary
Diabetes Mellitus 66.7%
Type 2 Diabetes Mellitus 33.3%
Bladder Cancer 33.3%
Fluid Retention 33.3%
Stress 33.3%
Concomitant
Diabetes Mellitus Non-insulin-dependent 75.4%
Drug Use For Unknown Indication 4.7%
Type 2 Diabetes Mellitus 4.7%
Diabetes Mellitus 3.2%
Hypertension 2.6%
Insulin-requiring Type 2 Diabetes Mellitus 1.1%
Blood Cholesterol Increased 0.9%
Relapsing-remitting Multiple Sclerosis 0.9%
Menopause 0.8%
Antibiotic Therapy 0.6%
Anticoagulant Therapy 0.6%
Blood Glucose Increased 0.6%
Insulin Resistant Diabetes 0.6%
Metastases To Bone 0.6%
Osteoporosis 0.6%
Pain 0.6%
Renal Failure Chronic 0.6%
Atrial Fibrillation 0.4%
Gout 0.4%
Neuropathy 0.4%
Weight Decreased 46.5%
Blood Glucose Increased 12.7%
Nausea 11.8%
Vomiting 6.1%
Weight Increased 3.8%
Tremor 2.3%
Somnolence 2.0%
Injection Site Haemorrhage 1.7%
Injection Site Pain 1.7%
Decreased Appetite 1.2%
Drug Effect Decreased 1.2%
Drug Ineffective 1.2%
Stress 1.2%
Therapeutic Response Unexpected 1.2%
Vision Blurred 1.2%
Blood Glucose Fluctuation 0.9%
Drug Ineffective For Unapproved Indication 0.9%
Dyspepsia 0.9%
Feeling Abnormal 0.9%
Hyperhidrosis 0.9%

Drug Data